Trial Details
COMPLETEDBasic Information
| Clinical ID | c1703 |
|---|---|
| Identifier | NCT04131504 |
| Trial Title | Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|IBD |
| Interventions | DRUG: Infliximab|DRUG: Adalimumab |
Participant Information
| Sponsor | Children's Hospital Medical Center, Cincinnati |
|---|---|
| City | Hartford |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2019-10-16 |
|---|---|
| Primary Completion Date | 2023-10-31 |
| Completion Date | 2023-10-31 |